These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11904462)

  • 21. The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma.
    Yuen HK; Yeung EF; Chan NR; Chi SC; Lam DS
    Cornea; 2002 Nov; 21(8):838-9. PubMed ID: 12410049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia.
    McKelvie PA; Daniell M
    Br J Ophthalmol; 2001 Sep; 85(9):1115-9. PubMed ID: 11520767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical mitomycin C for the treatment of conjunctival tumor.
    Ozcan AA; Sizmaz S; Yagmur M
    Ophthalmologica; 2007; 221(1):14-7. PubMed ID: 17183195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil.
    Midena E; Angeli CD; Valenti M; de Belvis V; Boccato P
    Br J Ophthalmol; 2000 Mar; 84(3):268-72. PubMed ID: 10684836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance.
    Chaparro Tapias TA; Díaz Díaz AL; Secondi R; Coy Villamil H; Sánchez España JC
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Nov; 93(11):558-561. PubMed ID: 30072188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical cyclosporine-a combined with mitomycin C for conjunctival and corneal squamous cell carcinoma.
    Tunc M; Erbilen E
    Am J Ophthalmol; 2006 Oct; 142(4):673-5. PubMed ID: 17011863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C.
    Heigle TJ; Stulting RD; Palay DA
    Am J Ophthalmol; 1997 Sep; 124(3):397-9. PubMed ID: 9439368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
    Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
    Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
    Dudney BW; Malecha MA
    Am J Ophthalmol; 2004 May; 137(5):950-1. PubMed ID: 15126170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Periocular allergic contact dermatitis following topical Mitomycin C eye drop application.
    Cumurcu T; Sener S; Cavdar M
    Cutan Ocul Toxicol; 2011 Sep; 30(3):239-40. PubMed ID: 21309691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N
    Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surgery and additional protontherapy for treatment of invasive and recurrent squamous cell carcinomas: technique and preliminary results].
    Caujolle JP; Maschi C; Chauvel P; Herault J; Gastaud P
    J Fr Ophtalmol; 2009 Dec; 32(10):707-14. PubMed ID: 19942315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.
    Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN
    Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Management of Squamous Cell Carcinoma of the Conjunctiva.
    Röck T; Bartz-Schmidt KU; Bramkamp M; Milla J; Bösmüller HC; Röck D
    Am J Case Rep; 2020 Feb; 21():e919751. PubMed ID: 32005796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of conjunctival melanoma].
    Salazar Méndez R; Baamonde Arbaiza B; de la Roz Martín P; Parra Rodríguez T
    Arch Soc Esp Oftalmol; 2014 Feb; 89(2):82-4. PubMed ID: 24269405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva.
    Shields CL; Demirci H; Marr BP; Masheyekhi A; Materin M; Shields JA
    Arch Ophthalmol; 2005 Jan; 123(1):109-13. PubMed ID: 15642823
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia.
    Daniell M; Maini R; Tole D
    Clin Exp Ophthalmol; 2002 Apr; 30(2):94-8. PubMed ID: 11886411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical chemotherapy for conjunctival melanoma.
    Finger PT; Milner MS; McCormick SA
    Br J Ophthalmol; 1993 Nov; 77(11):751-3. PubMed ID: 8280698
    [No Abstract]   [Full Text] [Related]  

  • 40. Expression pattern of sonic hedgehog and effect of topical mitomycin C on its expression in human ocular surface neoplasms.
    Fujita K; Miyamoto T; Okada Y; Ishikawa N; Saika S
    Jpn J Ophthalmol; 2008; 52(3):190-194. PubMed ID: 18661269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.